MedPath

A clinical study to assess how the time of consumption of anti-hypertensive medication affects the BP of patients of primary hypertension.

Phase 4
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2023/11/060317
Lead Sponsor
Dr. Ashiya Parveen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Newly diagnosed cases of primary hypertension who have been prescribed once-daily dose of any anti-hypertensive drug, as per discretion of treating physician.

2. Known cases of hypertension who require addition of another anti-hypertensive in once daily dosing.

Exclusion Criteria

1.Pregnant women.

2.Patients with Secondary Hypertension.

3.Patients in whom principal investigator is not allowed to randomize the dosing by the treating physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath